These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 1723008)

  • 21. Silymarin protection against major reactive oxygen species released by environmental toxins: exogenous H2O2 exposure in erythrocytes.
    Kiruthiga PV; Shafreen RB; Pandian SK; Devi KP
    Basic Clin Pharmacol Toxicol; 2007 Jun; 100(6):414-9. PubMed ID: 17516996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible structural role of the disaccharide unit in Fe-bleomycin before and after oxygen activation.
    Lehmann TE; Li Y
    J Antibiot (Tokyo); 2012 Jan; 65(1):25-33. PubMed ID: 22068157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bleomycin-dependent damage to the bases in DNA is a minor side reaction.
    Gajewski E; Aruoma OI; Dizdaroglu M; Halliwell B
    Biochemistry; 1991 Mar; 30(9):2444-8. PubMed ID: 1705818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catecholamine stimulation of copper dependent haemolysis: protective action of superoxide dismutase, catalase, hydroxyl radical scavengers and serum proteins (ceruloplasmin, albumin and apotransferrin).
    Løvstad RA
    Acta Pharmacol Toxicol (Copenh); 1984 May; 54(5):340-5. PubMed ID: 6464779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disulfiram may mediate erythrocyte hemolysis induced by diethyldithiocarbamate and 1,4-naphthoquinone-2-sulfonate.
    Lauriault VV; O'Brien PJ
    Arch Biochem Biophys; 1991 Jan; 284(1):207-14. PubMed ID: 1846514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of alpha-methyldopa binding to the erythrocyte membrane by superoxide dismutase.
    Green FA; Jung CY; Hui H
    Biochem Biophys Res Commun; 1980 Aug; 95(3):1037-42. PubMed ID: 7417298
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cytotoxic properties of the complex of the antineoplastic antibiotic bleomycetin and Bacillus intermedius ribonuclease].
    Kalacheva NV; Bulgakova RSh; Kazantseva NIu; Kurinenko BM
    Antibiot Khimioter; 1997; 42(4):16-20. PubMed ID: 9182501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interaction of copper (Cu++) with the erythrocyte membrane and 2,3-dimercaptopropanesulphonate in vitro: a source of activated oxygen species.
    Aaseth J; Ribarov S; Bochev P
    Pharmacol Toxicol; 1987 Oct; 61(4):250-3. PubMed ID: 3432203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of haemolysis by the macrophage synthesized antioxidant, 7,8-dihydroneopterin.
    Gieseg SP; Maghzal G; Glubb D
    Redox Rep; 2000; 5(2-3):98-100. PubMed ID: 10939282
    [No Abstract]   [Full Text] [Related]  

  • 30. Activated neutrophils induce erythrocyte immunoglobulin binding and membrane protein degradation.
    Weiss DJ; Murtaugh MP
    J Leukoc Biol; 1990 Nov; 48(5):438-43. PubMed ID: 2230594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A biphasic nature of the bleomycin-mediated degradation of DNA.
    Strekowski L; Mokrosz JL; Wilson WD
    FEBS Lett; 1988 Dec; 241(1-2):24-8. PubMed ID: 2461879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the carbamoyl group attached to an axial ligand portion of a novel bleomycin model on a dioxygen activating reaction.
    Shinozuka K; Ishikawa M; Arai T; Kohda J; Sawai H
    Chem Pharm Bull (Tokyo); 1998 Oct; 46(10):1635-8. PubMed ID: 9810698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of cisplatin on normal human erythrocytes in vitro.
    Dawson M; Brown EA; Barr RD
    Scand J Haematol; 1983 Sep; 31(3):283-6. PubMed ID: 6192486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in the cleavage of DNA by bleomycin under light (300-350 nm) and dark conditions.
    Douglas KT; Thakrar N; Minter SJ; Davies RW; Scazzochio C
    Cancer Lett; 1982 Sep; 16(3):339-45. PubMed ID: 6185218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of cancer with cryochemotherapy.
    Mir LM; Rubinsky B
    Br J Cancer; 2002 May; 86(10):1658-60. PubMed ID: 12085219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heavy metal binding to biological molecules: Identification of ligands by observation of 199Hg--1H coupling.
    Cass AE; Galdes A; Hill HA; McClelland CE; Storm CB
    FEBS Lett; 1978 Oct; 94(2):311-4. PubMed ID: 81146
    [No Abstract]   [Full Text] [Related]  

  • 37. If We Destroy Nature - We Destroy Ourselves.
    von Ungern-Sternberg BS; Grigg J
    Anesthesiology; 2022 Nov; 137(5):524-525. PubMed ID: 36264091
    [No Abstract]   [Full Text] [Related]  

  • 38. How Does Gelseminum Destroy Life?
    McElroy ZC
    Chic Med J; 1869 Jan; 26(1):16-20. PubMed ID: 37412442
    [No Abstract]   [Full Text] [Related]  

  • 39. Dexamethasone-(C21-phosphoramide)-[anti-EGFR]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency against pulmonary adenocarcinoma (A549).
    Coyne CP; Narayanan L
    Drug Des Devel Ther; 2016; 10():2575-97. PubMed ID: 27574398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of a covalent epirubicin-(C(3)-amide)-anti-HER2/neu immunochemotherapeutic utilizing a UV-photoactivated anthracycline intermediate.
    Coyne CP; Jones T; Bear R
    Cancer Biother Radiopharm; 2012 Feb; 27(1):41-55. PubMed ID: 22191802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.